Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’

Código QR

Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’

Guardado en:

Detalles Bibliográficos
Autores principales:	David A. Sykes, J. Robert Lane, Monika Szabo, Ben Capuano, Jonathan A. Javitch, Steven J. Charlton
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/3b5818ff24944d2888354db7faccd2e3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
por: David A. Sykes, et al.
Publicado: (2017)

Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects
por: Hugo Zeberg, et al.
Publicado: (2018)

Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies.
por: Tilahun Ali, et al.
Publicado: (2021)

The role of kinetic context in apparent biased agonism at GPCRs
por: Carmen Klein Herenbrink, et al.
Publicado: (2016)

Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
por: Dohyun Im, et al.
Publicado: (2020)

Electroconvulsive Therapy as a Corrector for Certain Side Effects of Antipsychotic Therapy
por: Yu. V. Bykov, et al.
Publicado: (2020)

Side- and similarity-biases during confidence conformity.
por: Winny W Y Yue, et al.
Publicado: (2021)

Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
por: Zachary Freyberg, et al.
Publicado: (2017)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang LF, et al.
Publicado: (2016)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio MC, et al.
Publicado: (2017)

New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
por: Anika Mann, et al.
Publicado: (2021)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Maria Lee, et al.
Publicado: (2021)

In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug
por: Yanan Xu, et al.
Publicado: (2018)

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata R, et al.
Publicado: (2016)

Network neighbors of drug targets contribute to drug side-effect similarity.
por: Lucas Brouwers, et al.
Publicado: (2011)

Reply to ‘Fetal side’ of the placenta: Anatomical mis-annotation of carbon particle ‘transfer’ across the human placenta
por: Eva Bongaerts, et al.
Publicado: (2021)

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Ana Caroline Brambilla Falvella, et al.
Publicado: (2021)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada R, et al.
Publicado: (2018)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang YP, et al.
Publicado: (2019)

Can Isolated Head Tremors Be an Extrapyramidal Symptom Associated with Lurasidone?—A Case Series
por: Suriya V, et al.
Publicado: (2021)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Ana Caroline Brambilla Falvella, et al.
Publicado: (2021)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose M, et al.
Publicado: (2021)

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
por: Sanne Hoekstra, et al.
Publicado: (2021)

Dopamine, behavior, and addiction
por: Roy A. Wise, et al.
Publicado: (2021)

Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability
por: Ami Peljto, et al.
Publicado: (2017)

Reply
por: Nazer H,Julio
Publicado: (2006)

Kinetic Properties of Microbial Exoenzymes Vary With Soil Depth but Have Similar Temperature Sensitivities Through the Soil Profile
por: Ricardo J. Eloy Alves, et al.
Publicado: (2021)

Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor
por: Hideaki Yano, et al.
Publicado: (2018)

Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum
por: Eduardo F. Gallo, et al.
Publicado: (2018)

Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter
por: Mark D. Condon, et al.
Publicado: (2019)

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
por: Arturo Casadevall, et al.
Publicado: (2014)

Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion
por: Kouji Fukuyama, et al.
Publicado: (2021)

Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea.
por: Hilla Ben-Pazi, et al.
Publicado: (2013)

Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies
por: Gopal S, et al.
Publicado: (2013)

Author's Reply
por: Manikandan Patchayappan, et al.
Publicado: (2016)

Author’s Reply
por: Manikandan Patchayappan, et al.
Publicado: (2016)

Reply to Hudaib
por: Leo Chen, et al.
Publicado: (2021)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
por: Suda A, et al.
Publicado: (2018)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu X, et al.
Publicado: (2014)